Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangaletti

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Cancer Research|April 9, 2020
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCsChiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2023
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitorsSara Manglaviti, Marta Bini, Giulia Apollonio, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
An inter- and intra-laboratory comparison of breath ¹³CO₂analysisF Perri, R M Zagari, J S Uebersax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Clinical Lung Cancer|March 23, 2023
The EU-funded I<sup>3</sup>LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With ImmunotherapyArsela Prelaj, Monica Ganzinelli, Francesco Trovo', et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Research Square|April 2, 2024
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphomaValeria Cancila, Gaia Morello, Giorgio Bertolazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOA Raimondi, S Lonardi, S Murgioni, et al.
The Journal of Clinical Investigation|July 17, 2025
Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark ZoneValeria Cancila, Giorgio Bertolazzi, Allison Sy Chan, et al.
Clinical Lung Cancer|January 23, 2024
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational ResearchArsela Prelaj, Monica Ganzinelli, Leonardo Provenzano, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Cancer Research|April 9, 2020
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCsChiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2023
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitorsSara Manglaviti, Marta Bini, Giulia Apollonio, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
An inter- and intra-laboratory comparison of breath ¹³CO₂analysisF Perri, R M Zagari, J S Uebersax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.
Clinical Lung Cancer|March 23, 2023
The EU-funded I<sup>3</sup>LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With ImmunotherapyArsela Prelaj, Monica Ganzinelli, Francesco Trovo', et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Research Square|April 2, 2024
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphomaValeria Cancila, Gaia Morello, Giorgio Bertolazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOA Raimondi, S Lonardi, S Murgioni, et al.
The Journal of Clinical Investigation|July 17, 2025
Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark ZoneValeria Cancila, Giorgio Bertolazzi, Allison Sy Chan, et al.
Clinical Lung Cancer|January 23, 2024
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational ResearchArsela Prelaj, Monica Ganzinelli, Leonardo Provenzano, et al.
Pageof 29